Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Alderman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|March 18, 2004
Uric acid: role in cardiovascular disease and effects of losartanMichael Alderman, Kala J V Aiyer
American Journal of Hypertension|August 28, 2014
Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohortPamela Singer, Hillel Cohen, Michael Alderman
Diabetes Care|October 2, 2009
Statin therapy and risk of developing type 2 diabetes: a meta-analysisSwapnil N Rajpathak, Dharam J Kumbhani, Jill Crandall, et al.
Journal of Hypertension|July 11, 2007
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countriesShanthi Mendis, Lars H Lindholm, Giuseppe Mancia, et al.
American Heart Journal|February 28, 2002
Myocardial function and geometry in hypertensive subjects with low levels of afterloadGerard P Aurigemma, Richard B Devereux, Giovanni De Simone, et al.
Heart Failure Reviews|June 20, 2014
Water and sodium in heart failure: a spotlight on congestionGaspare Parrinello, Stephen J Greene, Daniele Torres, et al.
American Journal of Hypertension|May 6, 2022
Low Diastolic Blood Pressure and Mortality in Older Women. Results From the Women's Health Initiative Long Life StudyBernhard Haring, Aileen P McGinn, Victor Kamensky, et al.
American Journal of Hypertension|February 28, 2002
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trialJohn B Kostis, Stuart Cobbe, Colin Johnston, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|March 18, 2004
Uric acid: role in cardiovascular disease and effects of losartanMichael Alderman, Kala J V Aiyer
American Journal of Hypertension|August 28, 2014
Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohortPamela Singer, Hillel Cohen, Michael Alderman
Diabetes Care|October 2, 2009
Statin therapy and risk of developing type 2 diabetes: a meta-analysisSwapnil N Rajpathak, Dharam J Kumbhani, Jill Crandall, et al.
Journal of Hypertension|July 11, 2007
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countriesShanthi Mendis, Lars H Lindholm, Giuseppe Mancia, et al.
American Heart Journal|February 28, 2002
Myocardial function and geometry in hypertensive subjects with low levels of afterloadGerard P Aurigemma, Richard B Devereux, Giovanni De Simone, et al.
Heart Failure Reviews|June 20, 2014
Water and sodium in heart failure: a spotlight on congestionGaspare Parrinello, Stephen J Greene, Daniele Torres, et al.
American Journal of Hypertension|May 6, 2022
Low Diastolic Blood Pressure and Mortality in Older Women. Results From the Women's Health Initiative Long Life StudyBernhard Haring, Aileen P McGinn, Victor Kamensky, et al.
American Journal of Hypertension|February 28, 2002
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trialJohn B Kostis, Stuart Cobbe, Colin Johnston, et al.
Pageof 1